Thus, researchers have generated a CAR-T cell strategy capable of expressing IL-8 receptors (CXCR1 or CXCR2) thereby enhancing their capacity of infiltrating solid tumors, consequently exerting an anti-tumor effect. Here, CXCR1 is linked to neoplasm.